Latest On Novozymes A/S (NVZMF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2024-05-01 05:59 EST | Dividend | A dividend of $2 has been announced on Apr 9, 2024. It will be paid May 3, 2024 with an ex-dividend date of May 1, 2024. | Neutral |  |
| 2023-02-03 04:59 EST | Dividend | A dividend of $6 has been announced on Jan 26, 2023. It will be paid Mar 7, 2023 with an ex-dividend date of Feb 3, 2023. | Neutral | |
| 2023-01-26 15:05 EST | News | Novozymes A/S GAAP EPS of DKK3.18, revenue of DKK4.53B | N/A | |
| 2022-08-11 19:33 EST | News | Novozymes A/S GAAP EPS of DKK5.87, revenue of DKK8.66B beats by DKK8.1B | N/A | |
| 2022-04-27 15:19 EST | News | Novozymes A/S GAAP EPS of DKK2.98, revenue of DKK4.37B | N/A | |
| 2022-03-17 05:59 EST | Dividend | A dividend of $5.5 has been announced on Feb 1, 2022. It will be paid Mar 21, 2022 with an ex-dividend date of Mar 17, 2022. | Neutral | |
| 2021-03-12 05:03 EST | Dividend | A dividend of $5.25 has been announced on Nov 30, -0001. It will be paid Mar 16, 2021 with an ex-dividend date of Mar 12, 2021. | Neutral | |
| 2021-02-05 01:32 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-03 05:04 EST | Earnings Estimate | An EPS average of $1.88 is estimated for the 2022 year. | Buy | |
| 2021-02-03 05:04 EST | Earnings Estimate | An EPS average of $0.37 is estimated for the quarter ending on June 30, 2021. | Sell | |
| 2021-02-02 18:06 EST | News | Novozymes A/S reports Q4 results | N/A | |
| 2020-11-26 22:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-21 10:03 EST | News | Stocks To Watch: Eyes On Best Buy, Vaccines And Holiday Cheer | N/A | |
| 2020-11-08 01:50 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 18:13 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-02 19:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-30 15:48 EST | Earnings Estimate | An EPS average of $0.45 is estimated for the quarter ending on March 31, 2021. | Buy | |
| 2020-10-21 10:20 EST | News | Novozymes A/S reports Q3 results | N/A | |
| 2020-09-26 15:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 07:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-15 18:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 11:07 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-13 05:55 EST | News | Novozymes A/S reports 1H results | N/A | |
| 2020-08-06 14:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 10:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 18:51 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 06:50 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 23:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 14:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 19:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 10:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 18:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 02:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 14:33 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 06:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 08:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 07:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 02:50 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 07:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-02 02:59 EST | News | Novozymes A/S reports Q1 results | N/A | |
| 2020-05-02 02:59 EST | News | Novozymes A/S 2020 Q1 - Results - Earnings Call Presentation | N/A | |
| 2020-05-02 02:58 EST | News | Novozymes (NVZMF) CEO Ester Baiget on Q1 2020 Results - Earnings Call Transcript | N/A | |
| 2020-05-01 18:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-30 10:12 EST | Earnings Estimate | An EPS average of $2.61 is estimated for the quarter ending on September 30, 2020. | Sell | |
| 2020-04-20 06:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-09 22:21 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-03 22:50 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-25 22:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-28 05:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-27 23:59 EST | Financials | Company financials have been released. | Neutral | |
About Novozymes A/S (NVZMF):
Novozymes A/S produces and sells industrial enzymes and microorganisms in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers agriculture solutions, including crop production, and animal health and nutrition solutions; liquefaction, saccharifaction, fermentation, cellulosic hydrolysis, and process enhancement solutions for bioenergy; baking, beverages, dairy, starch, and protein ingredients for the food and beverage industry; and laundry, dishwashing, and professional cleaning solutions for the household care industry. It also provides wastewater solutions, such as additives, biogas production, industrial bio cleaning, compound removal, odor control, and system start-up solutions; and textile solutions comprising denim abrasion and finishing, biopreparation, biopolishing bleach clean-up, and desizing solutions. In addition, the company offers forest products that include bleach boosting, deinking, fiber modification, effluent control, pitch and stickies control, and starch modification products; and leather solutions, which comprise biopreparation, degreasing, and re-bating. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis; and rTrypsin for cell culture. Novozymes A/S has collaboration with FMC Corporation to co-develop enzyme solutions. The company is based in Bagsvaerd, Denmark.
General
- Name Novozymes A/S
- Symbol NVZMF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorBasic Materials
- IndustryChemicals
- Full Time Employees 5,903
- Last Split Factor5:1
- Last Split Date2011-11-28
- Fiscal Year EndDecember
- Web URLhttp://www.novozymes.com
View More
Valuation
- Trailing PE 34.22
- Forward PE 34.13
- Price/Sales (Trailing 12 Mt.) 7.69
- Price/Book (Most Recent Quarter) 9.5
- Enterprise Value Revenue 1.25
- Enterprise Value EBITDA 3.61
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $1.71
- Next Year EPS Estimate $1.85
- Next Quarter EPS Estimate $0.47
- Profit Margin 20%
- Return on Assets 11%
- Return on Equity 25%
- Earnings Per Share $1.69
- Revenue Per Share $0
- Gross Profit 7.85 billion
- Quarterly Earnings Growth -7.6%
View More
ESG Rating
Highlights
- Market Capitalization 16.61 billion
- PEG Ratio 4.06
- Analyst Target Price $28.3
- Book Value Per Share $5.93
View More
Share Statistics
- Shares Outstanding 225.34 million
- Shares Float 206.54 million
- % Held by Insiders 885%
- % Held by Institutions 40.9%
View More
Technicals
- Beta 0.26
- 52 Week High $67.84
- 52 Week Low $39.35
- 50 Day Moving Average 62.53
- 200 Day Moving Average 60.76
View More
Dividends
- Forward Annual Dividend Rate $0.84
- Forward Annual Dividend Yield 1.31%
- Payout Ratio 57%
- Dividend Date 2018-03-16
- ExDividend Date 2021-03-12
- Dividend Per Share $0.84
- Dividend Yield 0%
View More
Novozymes A/S (NVZMF) Dividend Calendar:
NVZMF's last dividend payment was made to shareholders on March 16, 2018.
Novozymes A/S pays out 57% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Novozymes A/S (NVZMF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2020-12-31 | $3.45 billion | $0.37 | $0.41 | -9.76% |
| 2020-09-30 | 2020-12-31 | $3.43 billion | $0.38 | $2.45 | -84.4% |
| 2020-06-30 | 2020-09-30 | $N/A | $0.40 | $2.33 | -82.9% |
| 2020-03-31 | 2020-06-30 | $N/A | $0.34 | $2.79 | -87.68% |
| 2019-12-31 | 2020-03-31 | $559.96 million | $0.43 | $2.82 | -84.91% |
| 2019-09-30 | 2019-12-31 | $540.75 million | $0.49 | $2.65 | -81.55% |
| 2019-06-30 | 2019-09-30 | $522.85 million | $0.33 | $3.42 | -90.48% |
| 2019-03-31 | 2019-06-30 | $522.87 million | $0.48 | $2.69 | -82.33% |
| 2018-12-31 | 2019-03-31 | $570.4 million | $0.36 | $2.76 | -86.88% |
| 2018-09-30 | 2018-12-31 | $568 million | $0.44 | $2.76 | -83.97% |
| 2018-06-30 | 2018-09-30 | $546.38 million | $0.43 | $2.62 | -83.6% |
| 2018-03-31 | 2018-06-30 | $581.31 million | $0.42 | $2.57 | -83.84% |
| 2017-12-31 | 2018-03-31 | $592.26 million | $0.45 | $2.84 | -84.11% |
| 2017-09-30 | 2017-12-31 | $564.33 million | $0.43 | $2.69 | -83.94% |
| 2017-06-30 | 2017-09-30 | $543.64 million | $0.44 | $2.59 | -83.07% |
| 2017-03-31 | 2017-06-30 | $535.7 million | $0.38 | $2.57 | -85.24% |
| 2016-12-31 | 2017-03-31 | $3.71 billion | $0.37 | $2.59 | -85.71% |
| 2016-09-30 | 2016-12-31 | $0.38 | $2.63 | -85.56% | |
| 2016-06-30 | 2016-09-30 | $0.37 | $2.49 | -84.97% | |
| 2016-03-31 | 2016-06-30 | $0.37 | $2.43 | -84.89% | |
| 2015-12-31 | 2016-03-31 | $0.37 | $2.30 | -83.85% | |
| 2015-09-30 | 2015-12-31 | $0.33 | $2.35 | -86.06% | |
| 2015-06-30 | 2015-09-30 | $0.36 | $2.37 | -84.79% | |
| 2015-03-31 | 2015-06-30 | $0.33 | $2.23 | -85.27% | |
| 2014-12-31 | 2015-03-31 | $0.33 | $1.90 | -82.82% | |
| 2014-09-30 | 2014-12-31 | $0.32 | $1.92 | -83.59% | |
| 2014-06-30 | 2014-09-30 | $0.34 | $1.94 | -82.26% | |
| 2014-03-31 | 2014-06-30 | $0.34 | $1.91 | -82.02% | |
| 2013-12-31 | 2014-03-31 | $0.40 | $1.71 | -76.47% | |
| 2013-09-30 | 2013-12-31 | $0.32 | $1.80 | -81.95% | |
| 2013-06-30 | 2013-09-30 | $0.32 | |||
| 2013-03-31 | 2013-06-30 | $0.31 | |||
| 2012-12-31 | 2013-03-31 | $0.28 | |||
| 2012-09-30 | 2012-12-31 | $0.28 | |||
| 2012-06-30 | 2012-09-30 | $0.28 | |||
| 2012-03-31 | 2012-06-30 | $0.26 | |||
| 2011-12-31 | 2012-03-31 | $0.28 | |||
| 2011-09-30 | 2011-12-31 | $0.20 | |||
| 2011-06-30 | 2011-09-30 | $0.29 | |||
| 2011-03-31 | 2011-06-30 | $0.28 | |||
| 2010-12-31 | 2011-03-31 | $0.29 | |||
| 2010-09-30 | 2010-12-31 | $0.20 | |||
| 2010-06-30 | 2010-06-30 | $0.22 | |||
| 2010-03-31 | 2010-03-31 | $0.24 | |||
| 2009-12-31 | 2009-12-31 | $0.19 | |||
| 2009-09-30 | 2009-09-30 | $0.19 | |||
| 2009-06-30 | 2009-06-30 | $0.16 | |||
| 2009-03-31 | 2009-03-31 | $0.17 | |||
| 2008-12-31 | 2008-12-31 | $0.14 | |||
| 2008-09-30 | 2008-09-30 | $0.17 | |||
| 2008-06-30 | 2008-06-30 | $0.19 | |||
| 2008-03-31 | 2008-03-31 | $0.17 | |||
| 2007-12-31 | 2007-12-31 | $0.15 | |||
| 2007-09-30 | 2007-09-30 | $0.14 | |||
| 2007-06-30 | 2007-06-30 | $0.18 | |||
| 2007-03-31 | 2007-03-31 | $0.14 | |||
| 2006-12-31 | 2006-12-31 | $0.13 | |||
| 2006-09-30 | 2006-09-30 | $0.12 | |||
| 2006-06-30 | 2006-06-30 | $0.13 | |||
| 2006-03-31 | 2006-03-31 | $0.10 | |||
| 2005-12-31 | 2005-12-31 | $0.09 | |||
| 2005-09-30 | 2005-09-30 | $0.11 | |||
| 2005-06-30 | 2005-06-30 | $0.12 | |||
| 2005-03-31 | 2005-03-31 | $0.10 | |||
| 2004-12-31 | 2004-12-31 | $0.09 | |||
| 2004-09-30 | 2004-09-30 | $0.11 | |||
| 2004-06-30 | 2004-06-30 | $0.09 | |||
| 2004-03-31 | 2004-03-31 | $0.09 | |||
| 2003-12-31 | 2003-12-31 | $0.09 | |||
| 2003-09-30 | 2003-09-30 | $0.07 |
Novozymes A/S (NVZMF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | 530 million | 477 million | N/A | N/A | 66.49 million |
| Income Before Tax | 806 million | 888 million | N/A | N/A | 158.94 million |
| Selling General Administrative | 588 million | 562 million | N/A | N/A | 84.95 million |
| Gross Profit | 1.91 billion | 1.93 billion | N/A | N/A | 316.67 million |
| Ebit | 728 million | 894 million | N/A | N/A | 140.93 million |
| Operating Income | 754 million | 894 million | N/A | N/A | 140.93 million |
| Income Tax Expense | 152 million | 177 million | 162 million | 204 million | 20.56 million |
| Total Revenue | 3.45 billion | 3.43 billion | N/A | N/A | 559.96 million |
| Cost of Revenue | 1.54 billion | 1.51 billion | N/A | N/A | 243.28 million |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | 18.01 million |
| Net Income From Continuing Operations | 654 million | 711 million | N/A | N/A | 138.38 million |
| Net Income Applicable to Common Shares | 654 million | 711 million | 645 million | 815 million | 138.38 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | -810 million | N/A | N/A | N/A |
| Change to Liabilities | -201 million | 74 million | -203 million | -18.16 million | 33.58 million |
| Total Cash Flow from Investing Activities | -230 million | -810 million | -138 million | -62.73 million | -25.84 million |
| Net Borrowings | -356 million | 13 million | 913 million | 77.89 million | -70.08 million |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | -13.06 million | -160.3 million |
| Change to Operating Activities | -2 million | 13 million | -23 million | 750412.73 | -583958.66 |
| Change in Cash | N/A | 110 million | N/A | 9 million | -37.81 million |
| Total Cash from Operating Activities | 894 million | 1.45 billion | 963 million | 85.85 million | 147.45 million |
| Depreciation | N/A | N/A | N/A | 28.52 million | 43.5 million |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | -77 million | N/A | 26.41 million | -729948.32 |
| Change to Account Receivables | N/A | N/A | N/A | -28.67 million | -31.68 million |
| Other Cash Flow from Financing Activities | N/A | -1000000 | N/A | N/A | N/A |
| Change to Net Income | 23 million | 176 million | 84 million | -68.44 million | 10.22 million |
| Capital Expenditures | N/A | 227 million | N/A | 56.58 million | 23.65 million |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 9.27 billion | 9.32 billion | 9.89 billion | N/A | 1.34 billion |
| Total Stockholder Equity | 11.23 billion | 10.8 billion | 10.8 billion | N/A | 1.72 billion |
| Other Current Liabilities | 2.93 billion | 1.72 billion | N/A | N/A | 199.16 million |
| Total Assets | 20.51 billion | 20.13 billion | 20.71 billion | N/A | 3.07 billion |
| Common Stock | 570 million | 570 million | 570 million | 570 million | 87.35 million |
| Other Current Assets | 23 million | 100 million | N/A | N/A | 11.56 million |
| Retained Earnings | 11.26 billion | 10.6 billion | 10.34 billion | 10.12 billion | 1.62 billion |
| Other Liabilities | 4.72 billion | 1.15 billion | 1.14 billion | 1.01 billion | 159.54 million |
| Other Assets | 1.38 billion | 1.16 billion | 1.17 billion | 1.18 billion | 178.6 million |
| Cash | 1.18 billion | 856 million | 1.02 billion | N/A | 106.71 million |
| Total Current Liabilities | 4.16 billion | 4.28 billion | 4.8 billion | N/A | 710.64 million |
| Other Stockholder Equity | -600 million | -366 million | -105 million | 66 million | 11.41 million |
| Property, Plant & Equipment | 9.61 billion | 9.72 billion | 9.95 billion | 10.1 billion | 1.53 billion |
| Total Current Assets | 6.91 billion | 6.58 billion | 6.86 billion | N/A | 1.06 billion |
| Long Term Investments | N/A | N/A | N/A | N/A | 8.85 million |
| Net Tangible Assets | 8.68 billion | 8.18 billion | 8.14 billion | 8.85 billion | 1.43 billion |
| Short Term Investments | 119 million | 78 million | 22 million | N/A | N/A |
| Long Term Debt | N/A | N/A | 3.53 billion | N/A | 406.12 million |
| Inventory | 2.36 billion | 2.53 billion | 2.62 billion | N/A | 392.17 million |
| Accounts Payable | 1.1 billion | 992 million | 1.11 billion | N/A | 167.64 million |
Novozymes A/S (NVZMF) Chart:
Novozymes A/S (NVZMF) News:
Below you will find a list of latest news for Novozymes A/S (NVZMF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Novozymes A/S (NVZMF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Novozymes A/S (NVZMF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2007-08-14 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1131345/000114420407042775/0001144204-07-042775-index.htm |
| 2010-03-16 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1131345/000119380510000721/0001193805-10-000721-index.htm |
| 2010-06-02 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1131345/000119380510001584/0001193805-10-001584-index.htm |
| 2017-09-29 | F-6 POS | Post-effective amendments for immediately effective filing | https://www.sec.gov/Archives/edgar/data/1131345/000119380517002625/0001193805-17-002625-index.htm |
| 2019-11-22 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1131345/000119380519001753/0001193805-19-001753-index.htm |
| 2005-10-25 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999705043717/9999999997-05-043717-index.htm |
| 2005-11-09 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999705045404/9999999997-05-045404-index.htm |
| 2005-10-18 | 12G32BR | Exemptions for American Depository Receipts and Certain Foreign Securities | https://www.sec.gov/Archives/edgar/data/1131345/999999999705045694/9999999997-05-045694-index.htm |
| 2005-10-18 | ARS | Annual Report to Security Holders | https://www.sec.gov/Archives/edgar/data/1131345/999999999705045696/9999999997-05-045696-index.htm |
| 2005-10-18 | ARS | Annual Report to Security Holders | https://www.sec.gov/Archives/edgar/data/1131345/999999999705045697/9999999997-05-045697-index.htm |
| 2005-12-01 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999705047808/9999999997-05-047808-index.htm |
| 2006-01-04 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706000359/9999999997-06-000359-index.htm |
| 2006-02-06 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706004526/9999999997-06-004526-index.htm |
| 2006-02-24 | ARS | Annual Report to Security Holders | https://www.sec.gov/Archives/edgar/data/1131345/999999999706006728/9999999997-06-006728-index.htm |
| 2006-03-06 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706007393/9999999997-06-007393-index.htm |
| 2006-03-13 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706008765/9999999997-06-008765-index.htm |
| 2006-05-08 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706018638/9999999997-06-018638-index.htm |
| 2006-05-18 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706020519/9999999997-06-020519-index.htm |
| 2006-06-21 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706026238/9999999997-06-026238-index.htm |
| 2006-07-31 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706032473/9999999997-06-032473-index.htm |
| 2006-08-18 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706035816/9999999997-06-035816-index.htm |
| 2006-08-22 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706035993/9999999997-06-035993-index.htm |
| 2006-09-05 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706037333/9999999997-06-037333-index.htm |
| 2006-09-05 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706037411/9999999997-06-037411-index.htm |
| 2006-11-07 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706045073/9999999997-06-045073-index.htm |
| 2006-12-07 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706048485/9999999997-06-048485-index.htm |
| 2006-12-21 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706049730/9999999997-06-049730-index.htm |
| 2007-02-06 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999707005493/9999999997-07-005493-index.htm |
| 2007-02-20 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999707006589/9999999997-07-006589-index.htm |
| 2007-02-27 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999707007788/9999999997-07-007788-index.htm |
| 2007-02-27 | ARS | Annual Report to Security Holders | https://www.sec.gov/Archives/edgar/data/1131345/999999999707007927/9999999997-07-007927-index.htm |
| 2007-03-15 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999707011876/9999999997-07-011876-index.htm |
| 2007-04-18 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999707019518/9999999997-07-019518-index.htm |
| 2007-04-23 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999707020129/9999999997-07-020129-index.htm |
| 2007-05-02 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999707022154/9999999997-07-022154-index.htm |
| 2007-06-14 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999707028299/9999999997-07-028299-index.htm |
| 2007-06-25 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999707029702/9999999997-07-029702-index.htm |
| 2008-02-13 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999708006211/9999999997-08-006211-index.htm |
| 2008-02-25 | ARS | Annual Report to Security Holders | https://www.sec.gov/Archives/edgar/data/1131345/999999999708007733/9999999997-08-007733-index.htm |
| 2009-02-24 | ARS | Annual Report to Security Holders | https://www.sec.gov/Archives/edgar/data/1131345/999999999709004778/9999999997-09-004778-index.htm |